Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TechnologyAdvice

National Institute for Health and Care Excellence NICE logo

Cell Therapeutics fails to gain NICE backing for blood cancer drug

Watchdog says not enough evidence to show Pixuvri is more effective than current treatments

- PMLiVE

Emerging business models for pharma

The traditional hegemony of the old monolithic pharma company is beginning to give way to a new, more interconnected business structure

- PMLiVE

Accenture report captures industry’s multichannel priorities

New survey suggests US sales and marketing executives already revamping structure and delivery models

- PMLiVE

From marketing to medical: Pharma’s informational source shift

The changing role of medical information in HCP communications pathways

High staff turnover found in CROs

US research firm warns that pharma companies will assess CRO turnover rates

- PMLiVE

FDA approves return of morning sickness drug for pregnant women

Regulator confirms safety of Diclegis – formerly known as Bendectin

- PMLiVE

Tamiflu sales boost Roche results despite efficacy concerns

Pharma company reports total sales of $12.44bn in first quarter of 2013

- PMLiVE

First efficacy data for GSK/Prosensa’s muscular dystrophy candidate positive

Ups ante in race against Sarepta Therapeutics to market first Duchenne muscular dystrophy drug

- PMLiVE

PAN promotes Julia Straker to board of directors

Becomes director of strategic brand planning

Coulter Partners expands North American team

Madeline Barrett and Nancy McCloskey join New Jersey office

- PMLiVE

Additional NICE recommendation for Novartis’ Lucentis

Says drug can be used in patients with macular oedema caused by blockage of the veins in the retina

- PMLiVE

US-based Millennium launches blood cancer website

The Takeda Oncology Company roll out new multiple myeloma website

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links